Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust

Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust, reports selling shares on March 13 and 14, 2025.

Summary

• Saba Capital Management, L.P., a 10% owner of BlackRock Capital Allocation Term Trust (BCAT), filed a Form 4 detailing changes in beneficial ownership.
• On March 13, 2025, Saba Capital sold 84,916 shares of common stock at a price of $15.09 per share.
• On March 14, 2025, Saba Capital sold 65,878 shares of common stock at a price of $14.88 per share.
• Following these transactions, Saba Capital's beneficial ownership decreased to 11,818,748 shares.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the reduction in Saba Capital's stake, which could indicate a lack of confidence or a shift in investment strategy. However, the impact is likely limited as they still hold a significant position.

Negatives

• Saba Capital Management reduced its stake in BlackRock Capital Allocation Term Trust.

Risks

• Continued selling pressure from large shareholders like Saba Capital could negatively impact BCAT's stock price.

Industry Context

Hedge funds and activist investors like Saba Capital often adjust their positions in closed-end funds like BCAT to manage portfolio risk or capitalize on market opportunities.

Stakeholder Impact

• Shareholders may react to the news of Saba Capital reducing its stake.
• The market price of BCAT could be affected by these transactions.

Key Dates